Kathryn Davis, MD, MTR
As
"Validation of a Prognostic Index for Huntington’s Disease"
November 16, 2016
12:00 PM - 1:00 PM
Surgery Theater Ground White
Jeffrey D. Long, PhD
Professor, Department of Psychiatry,
Carver College of Medicine
Department of Biostatistics,
College of Public Health University of Iowa
Target Audience
This program has been designed for physicians, fellows, residents, medical students, physician assistants, professional nurses, advanced practice nurses, psychologists, and social workersin the medical specialties of internal medicine, neurology, physical medicine and rehabilitation, psychiatry and neurology, and radiology.
Series Educational Objectives
After completing this activity, participants should be able to:
- Learn established and novel treatments for common and unusual neurologic disease
- Learn the pathogenesis of common and unusual neurologic disease
- Learn established, evidence-based guidelines for team-based management of neurologic disease
Session Educational Objectives
After completing this activity, participants should be able to:
*Objective 1: Describe how age and CAG repeat expansion are related to the timing of motor onset in Huntington's
disease.
*Objective 2: Explain how the use of multiple data sets can influence the evaluation of Huntington's disease patients
and influence selection for clinical trials.
Accreditation
Physicians: The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Nurses: Penn Medicine Nursing is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Approval # 124-3-H-15
Designation of Credit
Physicians: The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses: Nurse participants will be awarded 1.0 contact hour.
Acknowledgement of Commercial Support* NONE
For more information, please contact
Corona Cohen
215-662-3360
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at the Perelman School of Medicine at the University of Pennsylvania and the Hospital of the University of Pennsylvania, Department of Nursing Education, Innovation and Professional Developmentfor individuals who are in a position to control the content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial interest that provide products or services that may be relevant to the content of this continuing education activity. For this purpose we consider relationships of the person involved to include financial relationships of a spouse or partner.
The intent of this policy is to ensure that Penn CME/CNE certified activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all content was conducted for all faculty presentations whose disclosure information was found to contain relationships that created a conflict of interest relevant to the topic of their presentation. In addition, all faculty were instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, CHCP, FACEHP, Director of CME,Zalman Agus, MD,Senior peer reviewerand Patricia A. Smith, MSN, RN-BC,Nursing professional development specialist of the HUP Department of Nursing Innovation and Development have disclosed that they have norelevant financial relationships with any commercial interests related to the content of this educational activity.
The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to the content of this educational activity:
Planning Committee Member Name
Geoffrey Aguirre, MD, PhD / Jean D. Luciano, CRNPChristopher Favilla, MD / Travis Lewis, MD, PhD
Presenter Name
The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity.
Planning Committee Member NameName of Commercial InterestRelationship
Raymond Price, MDGrifulsSpeaker
AccentureConsultant
Frances E. Jensen, MD, FACPEisai PharmaResearch
Presenter NameName of Commercial InterestRelationship
Jeffrey D. Long, PhDAzevan Inc and F. Hoffmann-La Roche Ltd, Huntington's disease clinical trial Consultant
DSMB for RAPID, Honorarium
Treatment-resistant depressionBoard Member
Relevant financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected
Disclosure of Unapproved Uses of Products
Presenter nameProductInvestigational and/or Off-label Use